Oncology Central

Prostate cancer test shows promise for identifying high-risk patients

Researchers at the Institute of Cancer Research (ICR) (London, UK) have developed a novel prostate cancer DNA test that can identify patients who have a high risk of developing prostate cancer in their lifetime. This could offer faster diagnosis and earlier treatment; potentially reducing prostate cancer cases.

Recently published in Nature Genetics, the test combines 63 new genetic variations in the DNA code that increases risk of prostate cancer, with over 100 other genetic variations previously linked to the disease.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.